1. Introduction
The incidence and mortality rates of fungal infections have increased over the last decade, making them a global public health concern as more epidemiological data are being published [
1].
Candida spp. are commonly found in human commensal flora [
2,
3,
4] and can cause superficial to fatal systemic infections. They are found in the oral, vaginal, and gastrointestinal mucosa, as well as on the skin and respiratory epithelium, and maintaining local homeostasis is essential to prevent the pathogenicity of these organisms [
5,
6].
Several species of
Candida spp. have pathogenic potential, with approximately 90% of invasive diseases caused by
C. albicans,
C. glabrata,
C. tropicalis,
C. parapsilosis, and
C. krusei [
7]. Oral candidiasis occurs when there is an imbalance between the host organism and the fungus. Under certain conditions, the fungus can transition from a benign commensal to a disease-causing agent. The most virulent strain,
C. albicans, responsible for around 80% of oral lesions, grows in yeast, pseudohyphae, and hyphae forms. It invades epithelial cells, causes tissue damage, and protects itself from salivary flow [
6,
8,
9].
The clinical treatment of infections caused by
Candida spp. is routinely carried out using polyenes, azole derivatives, allylamines, thiocarbamates, fluoropyrimidines, and echinocandins. However, these drugs are associated with undesirable side effects and toxicity [
10,
11]. Moreover, resistance to these commonly used antifungal agents among clinical strains has been widely reported. Thus, being cost-effective and easy to use, phytotherapy stands out as a potential alternative for research, especially given the scarcity of studies in dentistry [
12].
Citronella (
Cymbopogon nardus) is a popular plant used to extract essential oil in Brazil. The oil is incorporated into formulations as an insect repellent, with the main phytochemicals being citronellal, citronellol, and nerol, which are antiseptics [
13,
14,
15,
16,
17,
18,
19,
20]. Furthermore, the literature demonstrates its effectiveness both in isolated and combined use, showing good antimicrobial efficacy [
13,
14,
15,
16] and no cytotoxicity or toxicity in healthy tissues [
17,
21,
22]. Its use as a disinfectant agent for oral and maxillofacial prostheses has also been proven [
18]. Therefore, citronella has antibacterial and antifungal potential, opening new perspectives for controlling human infections.
Another natural compound with various biological activities, including antibacterial, antiviral, antioxidant, anti-inflammatory, immunomodulatory, and anticancer effects, is caffeic acid phenethyl ester (CAPE), one of the main active components of propolis [
19,
20,
23]. This compound exhibits potent anti-inflammatory and antioxidant activities [
24,
25]. Additionally, CAPE accelerates wound healing, reduces osteoclastogenesis, decreases tissue destruction caused by oxidative stress, and stimulates bone healing [
26].
Based on this information, and considering the necessity to achieve effectiveness without negatively impacting the local microflora, with minimal adverse effects and at affordable costs, the current study aimed to assess the antifungal, antioxidant, and irritative potential of citronella oil, either alone or in combination with CAPE, for the topical treatment of oral candidiasis. This study hypothesized that citronella oil alone or combined with CAPE would exhibit antifungal effects and inhibit the growth of Candida albicans species, would not demonstrate harmful irritative potential, and would possess antioxidant properties.
4. Discussion
The hypothesis that citronella oil alone and in combination with CAPE would exhibit antifungal effects and inhibit the growth of
Candida albicans was confirmed. Both compounds tested showed fungicidal action at different concentrations when used alone and in combination. According to the results obtained in the MIC/MFC assays, the solution containing citronella essential oil showed MIC/MFC values of 0.5 mg/mL. De Toledo et al. [
29] found similar results in their study when they evaluated the antifungal effect of citronella essential oil (
Cymbopogon nardus) against various standard and clinical strains of Candida (
C. albicans,
C. krusei,
C. glabrata,
C. tropicalis, and
C. parapsilosis). They discovered a range of MIC/MFC values between 250 and 1000 μg/mL. The present study obtained even better results for CAPE, which showed MIC/MFC values approximately 10 times lower than those of citronella, resulting in MIC/MFC values of 31 μg/mL. These values are in accordance with previous published studies. Sun et al. [
19] found MIC values of 32 to 64 μg/mL for CAPE against
C. albicans species in their study. De Barros et al. [
30] found MIC values for CAPE ranging from 16 to 64 μg/mL in
C. albicans species. The values of the present study fell within the range reported in the scientific literature.
A compound’s antifungal activity can be categorized as active or inactive based on the following MIC values: 50–500 µg/mL, strong/optimal activity; 600–1500 µg/mL, moderate activity; above 1500 µg/mL, weak activity or inactive product [
29,
31,
32]. Thus, the CAPE and citronella essential oil results suggest a strong/optimal activity. These results are in line with prior studies, confirming the antifungal properties of citronella essential oil and the CAPE on Candida fungal species [
17,
30,
33].
The compounds have been proven to have an antibiofilm effect when used alone or in combination. The concentrations of solutions containing citronella essential oil that achieved fungicidal results were 2.5 mg/mL for the 1 min treatment protocol and 1.25 mg/mL for the 6 h protocol, resulting in complete elimination of the biofilms. These results are consistent with studies published in the literature that investigated the effectiveness and antifungal properties of the essential oil from the
Cymbopogon nardus plant against Candida species, demonstrating promising results [
17,
34]. The active components found in citronella oil, such as citronellal, nerol, geraniol, and citronellol, have been shown in previous studies [
35,
36] to increase the fluidity and permeability of microorganism membranes. This can cause cellular disruptions or lysis [
37]. Additionally, geraniol and citronellal have been found to be effective against
C. albicans and other Candida species. This helps to explain why solutions containing citronella are highly effective, as demonstrated in the present study [
38,
39,
40].
In this study, the solution containing citronella essential oil utilized xanthan gum, a polysaccharide produced by Xanthomonas campestris. Xanthan gum is a commonly used water-based emulsifier and stabilizer in the food industry. It demonstrates good stability across different temperatures and pH ranges [
35,
38,
41]. The solution demonstrated satisfactory results and good antifungal and antibiofilm action, preserving its effect when used alone and when combined with CAPE.
Regarding CAPE, it was observed that the solution displayed strong antifungal action when used alone. It showed greater effectiveness at concentrations of 0.31 mg/mL and 0.15 mg/mL, completely inhibiting fungal growth. Similar results were found by Alfarrayeh et al. [
42], who discovered that CAPE has a high ability to inhibit planktonic growth and biofilm formation of different Candida species tested, as well as partially inhibiting the formation of mature biofilms of these fungi. The authors noted that the effect was dose-dependent for biofilm eradication, with concentrations ranging from 50 to 100 μg/mL. Additionally, the authors pointed out that CAPE exhibits its antifungal activity by inducing cell death in
Candida spp. through cell protoplasm shrinkage, abnormal cell and nuclear morphology, and distortion of cell walls and membranes, causing changes in surface micromorphology. However, it is still reported that the mechanisms of action of CAPE are not well established [
19].
We observed a positive and synergistic association between the two tested compounds. At three different concentrations (CAPE 0.3 mg/mL + Citro 5 mg/mL, CAPE 0.15 mg/mL + Citro 2.5 mg/mL, and CAPE 0.07 mg/mL + Citro 1.25 mg/mL), these associations completely killed the cells of the biofilms formed at both 2 h and 24 h. In the concentration of CAPE 0.03 mg/mL + Citro 0.6 mg/mL, the
C. albicans biofilm was partially inhibited for 24 h. In a study conducted by Sun et al. [
19], the combined use of CAPE with caspofungin against
C. albicans species was evaluated. The authors reported a synergistic effect, with the combination reducing the MIC values by 16 times compared to the individual values of each drug. This suggests that CAPE may enhance the efficacy of caspofungin in treating fungal infections caused by
C. albicans. Similarly, the combined effect of CAPE and the drug fluconazole on C. albicans was evaluated and it demonstrated positive synergistic activity. This combination enhanced the effectiveness of treatment against fluconazole-resistant
C. albicans, showing promise as a therapeutic option. The synergy was attributed to decreased MIC values in fluconazole-resistant clinical isolates [
43].
In a study by Khan et al. [
44], the antifungal activity of various essential oils, including those from the Cymbopogon genus, was evaluated against different clinical and conventional strains of
C. albicans. These herbal medicines were combined with the conventional drugs Amphotericin B and fluconazole, which are commonly used to treat fungal infections caused by
C. albicans. The authors concluded that combining isolated essential oils with conventional antifungals can improve the treatment of patients with candidiasis, particularly those with strains that are resistant to traditional treatments. Bioactive combinations can produce more effective results at lower concentrations by enhancing antifungal activity. This allows for a wider range of action, targeting more pathogens and reducing the likelihood of fungi developing resistance to the treatments [
45]. No previous studies have reported the combination of CAPE and citronella essential oil compounds. This study is scientifically and clinically significant due to the novel results obtained. It has opened new perspectives for treatment using natural products, which could lead to the development of products such as mouth rinses and antifungal mucosal adhesive ointments or gels, especially for conditions that are resistant to conventional antifungal treatments.
The HET-CAM test is an alternative to animal testing once the egg’s CAM (chorioallantoic membrane) has functional vascularization. It provides faster results, serving as a preliminary alternative to traditional animal testing [
46,
47,
48]. The observed effects include changes in the membrane and blood vessels. These effects consist of hemorrhage (increased bleeding from the blood vessels of the CAM), hyperemia (increased blood vessel diameter), and coagulation (intravascular or extravascular protein coagulation, which usually leads to increased CAM opacity). These effects are assessed by observing the fixation and reaction times of the solutions applied to the CAM [
44]. Based on these criteria, most of the solutions studied in this research were found to be non-irritating. The only exceptions were the isolated solution of CAPE 0.15 mg/mL and the combined solution of CAPE 0.038 mg/mL + CITRO 0.625 mg/mL, which were classified as mildly irritating. This mild irritation is likely due to the presence of DMSO in the solution, which was also observed in the CAPE control solution.
This study used two methods to evaluate antioxidant effectiveness. The FRAP assay (Ferric-Reducing Antioxidant Power) involves reducing the ferric-tripyridyltriazine (Fe
+3-TPZ) complex to the ferrous complex (Fe
+2-TPZ) in the presence of an antioxidant under acidic conditions. The resulting complex has a deep blue color and absorbs light at 593 nm. The FRAP assay is simple, fast, and can be carried out using automated, semi-automated, or manual methods [
49]. The antifungal action of CAPE may involve depriving cells of iron by forming insoluble complexes with iron ions, thus preventing their absorption [
40]. In this study, the presence of CAPE in the solutions increased their antioxidant capacity. The DPPH (2,2-diphenyl-1-picrylhydrazyl) radical-scavenging test was the second antioxidant assay to assess antioxidant activity. This method is based on electron transfer [
43]. The results indicated that the CAPE and CAPE + citronelle groups demonstrated a significant ability to scavenge DPPH, unlike the other groups, supporting the FRAP assays’ findings. In summary, the CAPE provided antioxidant properties to the solutions that were not present in citronelle and xanthan alone.
The FRAP and DPPH assays revealed that isolated CAPE has high antioxidant efficiency, capable of reducing Fe³⁺ to Fe²⁺ and neutralizing free radicals, with an EC50 of 13 ± 3 mg/mL. The combination of CAPE with citronella also showed significant antioxidant activity (EC50 of 32 ± 9 mg/mL), suggesting that citronella may complement the action of CAPE. Although isolated citronella and chlorhexidine solutions did not show relevant antioxidant activity, the combination of CAPE with citronella maintained good antioxidant efficacy. In summary, isolated CAPE is a potent antioxidant, and its combination with citronella retains considerable antioxidant capacity, indicating potential synergism. Noreen et al. [
45] found in silico molecules with antioxidant activity where DPPH and FRAP (%) values ranged between 51 and 68%, which are good indicators of efficacy [
50].
CAPE is already being used in modern medicine due to its favorable properties. Otan Ozden [
51] concluded that CAPE has a beneficial effect in reducing the local oxidative state of gingival tissues in experimental models of periodontitis. This is achieved by activating cellular defense mechanisms against oxidative stress, including decreases in superoxide dismutase (SOD), catalase (CAT), and glutathione S-transferase (GST) expression. CAPE also has good anti-inflammatory properties and can modulate the arachidonic acid cascade compared to other components of propolis [
20]. Additionally, CAPE can suppress the expression of inflammatory mediators induced by H
2O
2. Tolba [
20] reports other anti-inflammatory and antioxidant functions of CAPE, such as inhibition of immunoglobulin-mediated cutaneous passive anaphylaxis and reduction and suppression of histamine. These functions relate to neurodegenerative diseases and provide further evidence of CAPE’s potential therapeutic benefits.
The plant
Cymbopogon nardus is utilized for the extraction of essential oil. Although it has no antioxidant capacity similar to CAPE, studies report [
52] that citronella also has antioxidant properties. This is attributed to its high content of monoterpenes, although lower than that of gallic acid, which is used as a standard. Due to the monoterpenes found in its composition, citronella also exhibits anticancer activities, inhibiting the proliferation of LNCαP and HeLα cells [
49]. Additionally, the same study reported that citronella essential oil has anti-inflammatory activities by inhibiting lipoxygenase [
53].
The combination of CAPE with citronella at various concentrations showed positive results in all assays analyzed in this study. This led to decreased concentrations of the active principles, which is generally favorable as it decreases the solutions’ cytotoxic potential. Our results are consistent with those of Sun et al. [
43], who reported that CAPE combined with fluconazole exhibited good synergy, suggesting it could be an alternative method for combating
Candida albicans.
Our findings are important due to the increasing occurrence of oral infections, particularly Candida species such as C. tropicalis, C. glabrata, and C. guilliermondii, which are resistant to antifungal agents. Additionally, commercially available solutions like chlorhexidine can cause side effects. For these reasons, studying natural phytotherapeutic solutions shows promise for preventing denture-related stomatitis, providing an alternative method to reduce Candida colonization. While this study has focused on citronella and CAPE associations for potential future use in new formulations emphasizing their antifungal and antioxidant properties, these associations could also be investigated for many other potential uses based on these results.